Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-04

Clinical Trial Update: Medical Need of OAC Reversal

View source ↗

Summary

Clinical trial update for an oral anticoagulant reversal study in atrial fibrillation; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boehringer Ingelheim

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2019-03-04